|
Parameters
|
Evaluations
|
Placebo (n = 19)
|
GMCT (n = 19)
|
|---|
|
Mean ± SD
|
p value*
|
Mean ± SD
|
p value*
|
|---|
|
1-RM Bench press (kg)
|
Baseline
|
48.21 ± 8.89
|
–
|
49.21 ± 9.03
|
–
|
|
Day 14
|
49.00 ± 8.60
|
0.1034
|
55.47 ± 8.75
|
< 0.0001
|
|
Day 28
|
50.42 ± 8.38
|
0.1189
|
68.11 ± 8.82
|
< 0.0001
|
|
Day 42
|
51.63 ± 8.62
|
0.0471
|
72.68 ± 10.28
|
< 0.0001
|
|
1-RM Leg press (kg)
|
Baseline
|
67.79 ± 31.36
|
–
|
73.58 ± 21.33
|
–
|
|
Day 14
|
69.00 ± 30.73
|
0.2152
|
82.84 ± 20.79
|
< 0.0001
|
|
Day 28
|
71.00 ± 30.40
|
0.2134
|
95.11 ± 26.42
|
< 0.0001
|
|
Day 42
|
73.00 ± 30.14
|
0.0660
|
102.89 ± 25.20
|
< 0.0001
|
|
No. of maximum repetitions-Leg press
|
Baseline
|
4.26 ± 1.33
|
–
|
4.16 ± 3.32
|
–
|
|
Day 14
|
5.42 ± 1.12
|
< 0.0001
|
7.16 ± 2.99
|
< 0.0001
|
|
Day 28
|
6.05 ± 0.97
|
< 0.0001
|
9.26 ± 2.79
|
< 0.0001
|
|
Day 42
|
6.32 ± 1.11
|
< 0.0001
|
10.74 ± 2.56
|
< 0.0001
|
- *Intragroup comparison between baseline and respective days of evaluation in placebo and GMCT group using t-test (p < 0.05)
